Navigation Links
January American Naturalist highlights
Date:1/4/2008

ts. In order to study the consequences of the liberation of such compounds on competitive interactions between plants, Raynaud and his colleagues have developed a new model that simulates the release of these compounds and the uptake of nutrients by plants at the scale of individual roots. "Our model emphasizes the importance of soil water in determining the mobility of nutrients in the soil and therefore which plants will be able to get them," states Xavier Raynaud. "Roots behave essentially as independent units in dry soils, so plants interact primarily through the number of roots they make. However, in wet soils, plants can strongly influence their neighbors by releasing exudates from their roots or by rapidly taking up nutrients. We hope that this model will help unify divergent views of plant competition by providing a more comprehensive view of the mechanisms controlling nutrient fluxes in the soil."


"Nontrophic interactions, biodiversity, and ecosystem functioning: an interaction web model"
Alexandra Goudard (Ecole Normale Suprieure and Universit Pierre et Marie Curie) and Michel Loreau (McGill University)

Most ecological theories deal with simple consumerresource interactions. Scientists at Ecole Normale Suprieure (Paris) and McGill University provide a novel approach to incorporate nontrophic interactions, such as pollination and habitat modification, in ecosystem models, which allows them to study the dynamics of complex interaction webs.

Their model adds nontrophic interactions to a food web in the form of modifications of trophic interactions. It also tracks nutrient fluxes in the food web and hence satisfies the principle of mass conservation. Using this model, they show that nontrophic interactions can profoundly influence ecosystem properties such as species diversity, biomass, and production. In turn, the nature, prevalence, and strength of species interactions depend on species diversity. Counteri
'/>"/>

Contact: Rudy Faust
rfaust@press.uchicago.edu
773-834-0386
University of Chicago Press Journals
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Align Technology to Announce Fourth Quarter and 2007 Year End Financial Results on January 29, 2008
2. Somanetics Corporation to Release Fourth Quarter and Fiscal 2007 Financial Results and Host Conference Call January 23, 2008
3. January is National Glaucoma Awareness Month
4. Insulet Corporation to Present at the JPMorgan Healthcare Conference on January 8, 2008
5. Echo Healthcare Extends Stockholder Vote on Proposed Merger With XLNT Veterinary Care to January 4, 2008
6. Immtech Investor Conference Call Scheduled for January 3, 2008, at 1 PM
7. National Cervical Cancer Coalition Stresses Importance of Screening and Prevention During January Cervical Health Awareness Month
8. Gentiva(R) Health Services to Present January 8 at JPMorgan Healthcare Conference in San Francisco
9. Hospira to Present at the JPMorgan 26th Annual Healthcare Conference on January 9
10. Biodel Inc. to Present at 26th Annual JPMorgan Healthcare Conference on January 7th, 2008
11. NPS Pharmaceuticals to Present at the JPMorgan 26th Annual Healthcare Conference on January 9, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)... HR Consulting firm CPEhr, and Junior Achi...hadow Day for 30 high-students from Downtown Busin...cs such as labor law, interviewing techniques and ...f. (PRWEB) July 24, 2008 -- Los Angeles HR Consul...ofit organization, hosted a Job Shadow Day for 30 ...
(Date:7/24/2008)... As America's baby boomers age, more ...s such as diabetes that necessitate the use of med...celet jewelry gives a generation attractive incent...n. , (PRWEB) July 24, 200...g health conditions can make a statement in more w...
(Date:7/23/2008)... N.Y., July 24 /PRNewswire/ -- MediVoice(R), LLC, ... for e-Health and,e-Prescribing, has formed a stra...ovider of interactive, web-based, patient-centered...on systems to integrate and market its,mobile voic...Care(TM),(VTOC) system., "MediVoice is pleased to...
(Date:7/23/2008)...roblem For 10+ Years Even Though Some Kilns Emit M...ement Kilns in AL, CA, IA,IL, MD, MI, MT, NY, OR,...e-USNewswire/ -- For more than a decade,after Cong...rom cement,kilns across the nation, the U.S. Envir...ction. Now, a new study from Earthjustice and the,...
Breaking Medicine News(10 mins):Health News:CPEhr and Junior Achievement Prepare High-School Students For the Workforce 2Health News:CPEhr and Junior Achievement Prepare High-School Students For the Workforce 3Health News:Aging Baby Boomers Meld Life-saving Data and Style with Lauren's Hope Fashion Medical ID Bracelet 2Health News:Aging Baby Boomers Meld Life-saving Data and Style with Lauren's Hope Fashion Medical ID Bracelet 3Health News:MediVoice(R) Partners With VisionTree(R) to Integrate Its Voice-Activated e-Prescribing Solution Into VisionTree's VTOC(TM) Web-Based Patient Management System 2Health News:MediVoice(R) Partners With VisionTree(R) to Integrate Its Voice-Activated e-Prescribing Solution Into VisionTree's VTOC(TM) Web-Based Patient Management System 3Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 2Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 3Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 4Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 5Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 6Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 7
...that a migraine headache decreases over the years.... painful and do not last much long. These findin...he Society annual meeting in Chicago, by Carl Dahl...dical director and founder of the Gothenburg Migra...
...act that will be presented Monday at SLEEP 2007, a...d toddlers born prematurely occurs earlier than e...an among full-term infants. The study, authored b...f West Virginia University, consisted of the respo...
...gh, who was admitted to a hospital in East Delhi a...y raising speculations of a suicide attempt by hi... In a statement to the Delhi Police, Singh said th...e glass window panes broke when he banged his hand...
...worry about the ticking of their biological clocks...rugs that could delay menopause. The news was br...who told a press conference that researchers had f...uld be soon be developed into a pill or an injecti...
Other Medicine News:Health News:Ages Eases the Pain of Migraine 2Health News:Scientists Have Found Way to Delay Menopause 2
(Date:7/23/2008)...swire-FirstCall/ -- Dendreon Corporation,(Nasdaq: ...ndent Data,Monitoring Committee (IDMC) to review i...vival relating to the Company,s Phase 3 IMPACT (IM... also known as D9902B) clinical trial,of PROVENGE(...tigational,active cellular immunotherapy for the t...
(Date:7/22/2008)...RNewswire/ -- Nonin Medical, a leading innovator,o... 20 years, has entered,the clinical testing phase ...al oxygen saturation. Today,s most common applicat...ng of the regional blood oxygenation,in the brain ...comes from an ongoing clinical study at the,Duke U...
(Date:7/22/2008)...dy Confirms Tyrima Exhibits Excellent Drug-Like ...sults Support Initiation of Phase II Clinical Tria...wswire/ -- CeNeRx BioPharma,Inc., a clinical stag...e,treatments for diseases of the central nervous s...andidate Tyrima(TM) into Phase II trials for the,t...
(Date:7/22/2008)...th chemotherapy and pegylated enzyme produces s...erapy alone - - Pegylated enzyme ...FirstCall/ -- Halozyme Therapeutics,Inc. (Nasdaq:...nd,commercializing products targeting the extracel...positive pre-clinical animal efficacy data,for its...
Breaking Medicine Technology:Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 4Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 2Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 3Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 4Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 5Aflac and the American Association for Cancer Research Unite to Issue Inaugural Aflac Career Development Award for Childhood Cancer Research 4933 1Aflac and the American Association for Cancer Research Unite to Issue Inaugural Aflac Career Development Award for Childhood Cancer Research 4933 2Aflac and the American Association for Cancer Research Unite to Issue Inaugural Aflac Career Development Award for Childhood Cancer Research 4933 3Knowledge Based Reconstruction Demonstrates Accuracy in Obtaining Ventricular Volume and Function in Tetralogy of Fallot Patients According to Ventri 1921 1Knowledge Based Reconstruction Demonstrates Accuracy in Obtaining Ventricular Volume and Function in Tetralogy of Fallot Patients According to Ventri 1921 2Alexza Announces Positive Phase 1 Results With AZ 007 28Staccato 28R 29 Zaleplon 29 1919 1Alexza Announces Positive Phase 1 Results With AZ 007 28Staccato 28R 29 Zaleplon 29 1919 2Alexza Announces Positive Phase 1 Results With AZ 007 28Staccato 28R 29 Zaleplon 29 1919 3Alexza Announces Positive Phase 1 Results With AZ 007 28Staccato 28R 29 Zaleplon 29 1919 4Measurements Poor for Assessing Clinical Trials With Children 17915 1Measurements Poor for Assessing Clinical Trials With Children 17915 2
....H.--(BUSINESS WIRE)--May 24, 2007 - Bentley,Pharm...utical,company, today announced that a late breaki...pted for a poster presentation at the,American Dia...ago.,The abstract, entitled "Results of a Randomiz...y of Intranasal Insulin Spray,(Nasulin(TM)) and In...
...O, May 23, 2007 /PRNewswire-FirstCall/ -- Shire pl...of the,investigational medication guanfacine exten...), a selective,alpha-2A-adrenoceptor agonist. Thes...olled studies and two long-term phase III,open-lab...tric,Association (APA) annual meeting, demonstrate...
Other Medicine Technology:Bentley Late Breaking Abstract Accepted for Poster Presentation at,American Diabetes Association Scientific Sessions 2Bentley Late Breaking Abstract Accepted for Poster Presentation at,American Diabetes Association Scientific Sessions 3Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 2Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 3Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 4Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 5Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 6Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 7Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 8
...nts incorporate a layered design unique in the ind...to prevent stray electrosurgical burns along the s...e or capacitive coupling; a well-documented patien...l AEM Instruments provides a neutral return path f...
...nts incorporate a layered design unique in the ind...to prevent stray electrosurgical burns along the s...e or capacitive coupling; a well-documented patien...l AEM Instruments provides a neutral return path f...
...nts incorporate a layered design unique in the ind...to prevent stray electrosurgical burns along the s...e or capacitive coupling; a well-documented patien...l AEM Instruments provides a neutral return path f...
...nts incorporate a layered design unique in the ind...to prevent stray electrosurgical burns along the s...e or capacitive coupling; a well-documented patien...l AEM Instruments provides a neutral return path f...
Medicine Products: